Pharmafocus: Advances in Oncology available now!
pharmafile | September 30, 2016 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Pharmafocus, oncology, pharmafocus supplementÂ
The latest issue of Pharmafocus is now available, and with it comes Advances in Oncology, our supplement featuring all the latest in tumour research and treatment.
Inside you can find a range of valuable insight from industry experts. Anjali Shukla investigates checkpoint inhibitor drugs and how they may be paving a path to a cancer cure by influencing the human immune system, and Sean Murray speaks to Dr Ugur Sahin, CEO of BioNTech to discuss the rapidly approaching possibility of a universal cancer vaccine.
Also in the issue, AbbVie’s VP of oncology clinical development brings some encouraging signs from the blood cancer space, and Cancer Research UK’s Dr Rowena Sharp and Dr Catrin Middleton delve into the crucial area of precision medicine and how progress in the field is leading us ever-closer to truly personalised cancer care.
Related Content
Charity commits £800,000 to AI research into late breast cancer recurrence
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate …
Most advanced breast cancer patients treated in community settings, Phesi study finds
Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings …
BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination …
